Literature DB >> 7917076

Drug-induced disorders of bone metabolism. Incidence, management and avoidance.

G Jones1, P N Sambrook.   

Abstract

Calcium homeostasis depends upon the interplay of intestinal calcium absorption, renal excretion and skeletal mobilisation of calcium, mediated through bone formation and resorption, which are closely coupled in the adult skeleton. Serum calcium is extremely important for maintenance of normal cellular functions and is regulated by the major calciotropic hormones, parathyroid hormone (PTH), 1,25-dihydroxy-vitamin D and calcitonin. Certain drugs can interfere with calcium metabolism by effects at different stages in calcium metabolism, and a knowledge of the mechanism of drug action is generally helpful in understanding the various resultant clinical skeletal syndromes. Corticosteroids, for example, have profound effects at multiple stages of calcium metabolism, resulting in decreased bone formation and enhanced bone resorption leading to accelerated osteoporosis. Drugs such as aluminium and anticonvulsants impair mineralisation, leading to osteomalacia. Other drugs, such as fluoride, are employed for their known effects on bone, but in excess dosage can be harmful by producing mineralisation defects. Management of these conditions will be discussed in this review.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7917076     DOI: 10.2165/00002018-199410060-00006

Source DB:  PubMed          Journal:  Drug Saf        ISSN: 0114-5916            Impact factor:   5.606


  87 in total

1.  Loss of vertebral bone density in heart transplant patients.

Authors:  J S Muchmore; D K Cooper; Y Ye; V T Schlegel; N Zuhdi
Journal:  Transplant Proc       Date:  1991-02       Impact factor: 1.066

2.  Bone status in nonambulant, epileptic, institutionalized youth. Improvement with vitamin D therapy.

Authors:  M H Fischer; W N Adkins; B H Liebl; S C VanCalcar; J A Marlett
Journal:  Clin Pediatr (Phila)       Date:  1988-10       Impact factor: 1.168

3.  Radiologic bone changes and hypocalcemia with anticonvulsant therapy in epilepsy.

Authors:  E A Sotaniemi; H K Hakkarainen; J A Puranen; R O Lahti
Journal:  Ann Intern Med       Date:  1972-09       Impact factor: 25.391

4.  Prophylactic fluoride treatment and aged bones.

Authors:  J Inkovaara; R Heikinheimo; K Jarvinen; U Kasurinen; H Hanhijarvi; E Iisalo
Journal:  Br Med J       Date:  1975-07-12

Review 5.  A half-century of community water fluoridation in the United States: review and commentary.

Authors:  L W Ripa
Journal:  J Public Health Dent       Date:  1993       Impact factor: 1.821

6.  Bone histomorphometry in corticosteroid-induced osteoporosis and Cushing's syndrome.

Authors:  P J Meunier; D W Dempster; C Edouard; M C Chapuy; M Arlot; S Charhon
Journal:  Adv Exp Med Biol       Date:  1984       Impact factor: 2.622

7.  Combined treatment with cyclosporin A and cortisone acetate minimizes the adverse bone effects of either agent alone.

Authors:  C Movsowitz; M Schlosberg; S Epstein; F Ismail; M Fallon; S Thomas
Journal:  J Orthop Res       Date:  1990-09       Impact factor: 3.494

8.  Histological and electron microprobe studies of mineralisation in aluminium-related osteomalacia.

Authors:  B F Boyce; J Byars; S McWilliams; M Z Mocan; H Y Elder; I T Boyle; B J Junor
Journal:  J Clin Pathol       Date:  1992-06       Impact factor: 3.411

9.  Aluminum-related bone disease in mild and advanced renal failure: evidence for high prevalence and morbidity and studies on etiology and diagnosis.

Authors:  A J Smith; M C Faugère; K Abreo; P Fanti; B Julian; H H Malluche
Journal:  Am J Nephrol       Date:  1986       Impact factor: 3.754

Review 10.  Aluminum: effects on bone and role in the pathogenesis of renal osteodystrophy.

Authors:  W G Goodman; M E Duarte
Journal:  Miner Electrolyte Metab       Date:  1991
View more
  4 in total

Review 1.  Drug-induced rheumatic disorders: incidence, prevention and management.

Authors:  P Vergne; P Bertin; C Bonnet; C Scotto; R Trèves
Journal:  Drug Saf       Date:  2000-10       Impact factor: 5.606

Review 2.  Drug-induced musculoskeletal disorders.

Authors:  Bernard Bannwarth
Journal:  Drug Saf       Date:  2007       Impact factor: 5.228

3.  Chronic administration of anticonvulsants but not antidepressants impairs bone strength: clinical implications.

Authors:  P W Gold; M G Pavlatou; D Michelson; C M Mouro; M A Kling; M-L Wong; J Licinio; S A Goldstein
Journal:  Transl Psychiatry       Date:  2015-06-02       Impact factor: 6.222

4.  Complexation and sequestration of BMP-2 from an ECM mimetic hyaluronan gel for improved bone formation.

Authors:  Marta Kisiel; Agnieszka S Klar; Manuela Ventura; Jos Buijs; Marc-Krystelle Mafina; Simon M Cool; Jöns Hilborn
Journal:  PLoS One       Date:  2013-10-22       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.